A comparative study of palonosetron and ondansetron in prevention of post operative nausea and vomiting in laparoscopic cholecystectomy surgery
Journal Title: Indian Journal of Clinical Anaesthesia - Year 2017, Vol 4, Issue 4
Abstract
Introduction: In this randomized, double-blind study we evaluated the relative efficacy of palonosetron (a new, selective 5hydroxytryptamine [5-HT3] receptor antagonist) and ondansetron in preventing postoperative nausea and vomiting (PONV) in patients undergoing laparoscopic cholecystectomy surgery. Materials and Method: Patients were given either palonosetron 0.075 mg (n = 50) or ondansetron 8 mg (n = 50) intravenously, just before anaesthesia. The occurrence of nausea and vomiting and the severity of nausea according to a visual analogue scale were monitored immediately after the end of surgery and during the following 24 hour post surgical period in time intervals of 0-4,4-8,8-12 and 12-24 hour period. Result: The incidence of PONV and nausea (not vomiting) was significantly lower in the palonosetron group than in the ondansetron group during the 24 hour post surgical period (P < 0.05). More patients in the palonosetron group had a complete response (no PONV and no need of rescue antiemetic) compared with the ondansetron group. The need for rescue antiemetics was significantly lower in the palonosetron group than in the ondansetron group during the 24 hour post surgical period (P <0.05). The severity of nausea (VAS) and incidence of adverse effects were not significantly different between the two groups. The incidence of PONV was significantly lower in the palonosetron group compared with the ondansetron group (32% vs 56%, respectively). Conclusion: Palonosetron 0.075 mg was more effective than ondansetron 8 mg in preventing postoperative nausea and vomiting (PONV).
Authors and Affiliations
Manish Khandelwal, Amit Kulshrestha, Priyanka Saini, Meenaxi Sharma
Keywords
Related Articles
- EP ID EP315019
- DOI 10.18231/2394-4994.2017.0093
- Views 93
- Downloads 0
Hip replacement in a patient of sickle cell disease: an anaesthetic challenge
Majority of surgical procedures in patients with sickle cell disease are a result of the disease process itself and require intervention for either treatment or prevention of certain complications. Avascular necrosis of...
Osteopetrosis – How much do we know?
Osteopetrosis Marble Bone Disease refers to a group of disorders of skeleton characterized by increased bone density on radiographs We should be aware of this entity as due to difficult airway and sclerotic spine anesthe...
Comparison of administration of intraperitoneal bupivacaine and intraperitoneal bupivacaine with dexmedetomidine in post laparoscopic cholecystectomy patients for post operative pain relief
Introduction Intraperitoneal administration of local anesthetic found to be effective in controlling postoperative pain in laparoscopic surgeries So this prospective study was conducted to compare antinociceptive effect...
Comparative evaluation of the clinical efficacy of 0.5% levobupivacaine and 0.5% racemic bupivacaine in epidural anaesthesia for elective varicose vein surgery
Background and Aim: Racemic bupivacaine is known to be the most cardio toxic among the amide local anaesthetic. In search of an alternative it was found that the levo enantiomer has a better safety profile. This purpose...
Optimal dose of methylprednisolone for reduction of propofol injection pain: A randomized, double-blind, placebo controlled study
Introduction and Aims Propofol 26diisopropylphenol used for the induction of anaesthesia often causes mild to severe pain on injection for which various methods have been tried but with conflicting results We designed a...